Shionogi & Co Ltd banner
S

Shionogi & Co Ltd
TSE:4507

Watchlist Manager
Shionogi & Co Ltd
TSE:4507
Watchlist
Price: 3 410 JPY 0.03%
Market Cap: ¥3T

Relative Value

The Relative Value of one Shionogi & Co Ltd stock under the Base Case scenario is hidden JPY. Compared to the current market price of 3 410 JPY, Shionogi & Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Shionogi & Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
Shionogi & Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Shionogi & Co Ltd
TSE:4507
2.9T JPY 6.2 14.9 11.8 13.2
US
Eli Lilly and Co
NYSE:LLY
930.7B USD 14.3 45.1 30.4 32.4
US
Johnson & Johnson
NYSE:JNJ
581.6B USD 6.2 21.7 15.1 18.5
CH
Roche Holding AG
SIX:ROG
254.1B CHF 4.1 19.8 11.7 13.2
CH
Novartis AG
SIX:NOVN
231.8B CHF 5.3 21.4 13.3 17
UK
AstraZeneca PLC
LSE:AZN
221.9B GBP 5.1 29.2 16.2 22.8
US
Merck & Co Inc
NYSE:MRK
286.1B USD 4.4 15.7 9.7 11.8
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.6 10.7 7.9 9.3
US
Pfizer Inc
NYSE:PFE
151.1B USD 2.4 19.4 7.5 10
US
Bristol-Myers Squibb Co
NYSE:BMY
118.9B USD 2.5 16.9 7.1 8.8
P/E Multiple
Earnings Growth PEG
JP
S
Shionogi & Co Ltd
TSE:4507
Average P/E: 21.5
14.9
12%
1.2
US
Eli Lilly and Co
NYSE:LLY
45.1
32%
1.4
US
Johnson & Johnson
NYSE:JNJ
21.7
7%
3.1
CH
Roche Holding AG
SIX:ROG
19.8
14%
1.4
CH
Novartis AG
SIX:NOVN
21.4
14%
1.5
UK
AstraZeneca PLC
LSE:AZN
29.2
26%
1.1
US
Merck & Co Inc
NYSE:MRK
15.7
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.7
1%
10.7
US
Pfizer Inc
NYSE:PFE
19.4
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
16.9
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
S
Shionogi & Co Ltd
TSE:4507
Average EV/EBITDA: 43.2
11.8
17%
0.7
US
Eli Lilly and Co
NYSE:LLY
30.4
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
15.1
2%
7.5
CH
Roche Holding AG
SIX:ROG
11.7
6%
2
CH
Novartis AG
SIX:NOVN
13.3
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
16.2
13%
1.2
US
Merck & Co Inc
NYSE:MRK
9.7
3%
3.2
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
7.9
1%
7.9
US
Pfizer Inc
NYSE:PFE
7.5
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.1
-10%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
S
Shionogi & Co Ltd
TSE:4507
Average EV/EBIT: 92.9
13.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
32.4
22%
1.5
US
Johnson & Johnson
NYSE:JNJ
18.5
7%
2.6
CH
Roche Holding AG
SIX:ROG
13.2
5%
2.6
CH
Novartis AG
SIX:NOVN
17
9%
1.9
UK
AstraZeneca PLC
LSE:AZN
22.8
21%
1.1
US
Merck & Co Inc
NYSE:MRK
11.8
6%
2
IE
E
Endo International PLC
LSE:0Y5F
865
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.3
3%
3.1
US
Pfizer Inc
NYSE:PFE
10
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.8
-7%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett